June 16, 2020

Dear Friends,


The Centers for Disease Control and Prevention published testing guidelines for nursing home residents and healthcare personnel and guidance for high-density critical infrastructure workplaces after a COVID-19 case is identified.

The Food and Drug Administration revoked the Emergency Use Authorization for hydroxychloroquine sulfate and chloroquine phosphate because they determined that these two drugs are unlikely to be effective in treating COVID-19.

The Department of Health and Human Services(HHS) released guidance implementing Section 18115 of the CARES Act, requiring laboratories to report certain demographic data, including race, ethnicity, age, and sex, along with the results from SARS-CoV-2 tests each such test to HHS.

The Centers for Medicare and Medicaid Services published a document recording all actions it has taken to combat COVID-19.

The National Institutes of Health, via the All of Us Research Program, will use its participant base to learn more about COVID-19 antibody testing, the use of electronic health records, and the overall impact of the pandemic.

The Federal Reserve seeks input on plans to offer loans to small- and mid-sized nonprofit organizations as part of its "Main Street Lending Program" designed to keep employers going during the pandemic.

Until next time, this is your doctor's note.

Congressman Michael C. Burgess, M.D.